XGN peer analysis
Exagen (XGN) against its competitors: price, today's move, 1-year return and market value side by side.
XGN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACRS Aclaris Therapeutics | $4.16 | -2.00% | 79.09% | $659.03M |
| BIOA BioAge Labs | $5.80 | 1.93% | -20.11% | $266.56M |
| LFCR Lifecore Biomedical | $6.38 | 0.16% | -6.86% | $241.84M |
| MDXH MDxHealth | $0.16 | 0.57% | -96.48% | $15.07M |
| NEO NeoGenomics | $16.95 | -3.69% | 68.15% | $2.21B |
| SGHT Sight Sciences | $10.73 | -2.50% | 84.45% | $596.64M |
| SMTI Sanara MedTech | $31.56 | -1.68% | 13.24% | $289.97M |
| STXS Stereotaxis | $1.14 | 4.59% | -58.09% | $114.23M |
| TKNO Alpha Teknova | $8.75 | 2.34% | 85.77% | $539.90M |
| VNDA Vanda Pharmaceuticals | $4.05 | -0.98% | -7.95% | $244.90M |
| XGN Exagen | $5.49 | -22.68% | -45.08% | $127.18M |
- XGN's peers: ACRS (Aclaris Therapeutics), BIOA (BioAge Labs), LFCR (Lifecore Biomedical), MDXH (MDxHealth), NEO (NeoGenomics), SGHT (Sight Sciences), SMTI (Sanara MedTech), STXS (Stereotaxis).
Updated 2026-11-11 00:49 UTC